← Open Payments lookup

JONATHAN SHACK: Open Payments

NPI 1629066626 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$391 in 15 payments from 6 companies in 2025. Trend: 2023 $243 · 2024 $349 · 2025 $391

Food & beverage: $391
CompanyPaymentsAmount
Alkermes, Inc.6$127
Janssen Pharmaceuticals, Inc2$81
Teva Pharmaceuticals USA, Inc.3$63
Otsuka America Pharmaceutical, Inc.2$54
E.R. Squibb & Sons, L.L.C.1$39
Luye Pharma (USA) Ltd.1$26

Products named: ARISTADA, INVEGA SUSTENNA, UZEDY, ABILIFY ASIMTUFII, COBENFY, ERZOFRI EXTENDED-RELEASE.

Industry payments across PA — which companies pay providers there.